Assessing ‘no evidence of disease activity’ status in patients with relapsing–remitting multiple sclerosis: a long-term follow-up

INTRODUCTION: Multiple Sclerosis (MS) is a chronic inflammatory demyelinating disease of the CNS with an autoimmune pathogenesis. Over the years, numerous disease-modifying therapies (DMTs) have proven effective in disease control; to date, there is a need to identify a personalized treatment effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Zilli, Chiara, Scribani Rossi, Pietro, Di Stadio, Arianna, Fratino, Mariangela, Giuliani, Giada, Annecca, Rosanna, Russo, Gaetano, Di Piero, Vittorio, Altieri, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440375/
https://www.ncbi.nlm.nih.gov/pubmed/37609659
http://dx.doi.org/10.3389/fneur.2023.1187851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440375/
https://www.ncbi.nlm.nih.gov/pubmed/37609659
http://dx.doi.org/10.3389/fneur.2023.1187851

Ejemplares similares